BioMed, University of California open cancer research center in San Diego

The University of California San Diego (UC San Diego) and BioMed Realty have opened the Center for Novel Therapeutics (CNT) – a new cancer research center at the former’s Science Research Park in San Diego, California.

The cancer research center in San Diego, which spans 137,500sft, has been developed with an investment of $92 million by BioMed Realty, a life science real estate firm.

The Center for Novel Therapeutics is expected to operate as the newest dedicated oncology research center in San Diego. The cancer research center will be equipped with the best-in-class facilities to advance life-changing therapies for cancer patients apart from featuring the first academic-industry drug discovery incubator site in the Californian city.

Center for Novel Therapeutics – a new cancer research center in San Diego

Center for Novel Therapeutics – a new cancer research center in San Diego. Photo courtesy of BioMed Realty.Tim Schoen – president and CEO, BioMed Realty said: “We are thrilled to announce the grand opening of the Center for Novel Therapeutics, a cutting-edge research building that will foster one of the nation’s most vibrant life science communities in California.

“It is an honor to partner with UC San Diego to promote innovative therapeutics and to support researchers and academics to expand and accelerate life-changing solutions worldwide.”

The Center for Novel Therapeutics is said to include the first academic-industry drug discovery incubator site in San Diego and strengthen new treatments for cancer patients by integrating the expertise of UC San Diego Moores Cancer Center with private sector companies.

Pradeep K Khosla – Chancellor, UC San Diego, commenting on the opening of the Center for Novel Therapeutics, said: “The Center for Novel Therapeutics partnership with BioMed Realty is going to change the face of patient care by bringing new therapies from research to market more efficiently than ever before.

“These types of forward-thinking partnerships help UC San Diego move closer to its goal of becoming a preferred destination for students, researchers, patients and the community.”

The Center for Novel Therapeutics was awarded LEED Gold Certification for incorporating high efficiency water-cooled central cooling, LED energy efficient light fixtures, and photo-voltaic solar panels.

Providing approximately 1.3 million jobs, the California state’s life science industry generated total revenue of $346 billion in 2018.

BioMed Realty is a Blackstone portfolio company that has invested approximately $1.1 billion in life science-focused real estate projects in the state of California since its privatization in 2016.

Related posts

• ExeGi Pharma announces probiotic Visbiome clinical trial in MS patients (0)
• Equashield CSTD now available for oncology nurses in Japan (0)
• Boehringer Ingelheim bags Ofev FDA approval for SSc-ILD (0)
• Maruho, X-Chem collaborate to advance drug discovery (0)
• OncoCyte to acquire Razor Genomics to advance lung cancer diagnosis (0)
• Researchers develop new AI-driven model for drug discovery (0)
• Vertex to acquire Semma Therapeutics to advance stem cell-based treatments for type 1 diabetes (0)
• Puma secures FDA orphan drug status for NERLYNX in breast cancer with brain metastases (0)
• Fresenius Kabi launches Phenylephrine Hydrochloride Injection, USP in US (0)
• Valo Therapeutics licenses PeptiENV technology from the University of Helsinki (0)

The post BioMed, University of California open cancer research center in San Diego appeared first on PharmaNewsDaily.com.